{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:36:30Z","timestamp":1790314590171,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,9,8]],"date-time":"2009-09-08T00:00:00Z","timestamp":1252368000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1038\/sj.bjc.6605292","type":"journal-article","created":{"date-parts":[[2009,9,8]],"date-time":"2009-09-08T16:40:53Z","timestamp":1252428053000},"page":"1066-1073","source":"Crossref","is-referenced-by-count":88,"title":["Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial"],"prefix":"10.1038","volume":"101","author":[{"given":"G","family":"Ferrandina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Sallustio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Fagotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Vizzielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Paglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Cucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Margariti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Aquilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Garganese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,8]]},"reference":[{"key":"BF6605292_CR1","doi-asserted-by":"publisher","first-page":"676.e1","DOI":"10.1016\/j.ajog.2007.10.495","volume":"197","author":"GD Aletti","year":"2007","unstructured":"Aletti GD, Dowdy JL, Podratz KL, Cliby WA (2007) Relationship among surgical complexity, short-term morbidity and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol 197: 676.e1\u2013676.e7","journal-title":"Am J Obstet Gynecol"},{"key":"BF6605292_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1200\/JCO.2006.07.7800","volume":"25","author":"AE Axtell","year":"2007","unstructured":"Axtell AE, Lee MH, Bristow RE, Dowdy SC, Cliby WA, Raman S, Weaver JP, Gabbay M, Ngo M, Lentz S, Cass I, Li AJ, Karlan BY, Holschneider CH (2007) Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol 25: 384\u2013389","journal-title":"J Clin Oncol"},{"key":"BF6605292_CR3","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1002\/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A","volume":"89","author":"RE Bristow","year":"2000","unstructured":"Bristow RE, Duska LR, Lambrou NC, Fishman EK (2000) A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89: 1532\u20131540","journal-title":"Cancer"},{"key":"BF6605292_CR4","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20: 1248\u20131259","journal-title":"J Clin Oncol"},{"key":"BF6605292_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ygyno.2008.04.042","volume":"110","author":"JL Brun","year":"2008","unstructured":"Brun JL, Rouzier R, Uzan S, Dara\u00ef E (2008) External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score. Gynecol Oncol 110: 354\u2013359","journal-title":"Gynecol Oncol"},{"key":"BF6605292_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1471-0528.2002.01216.x","volume":"109","author":"J Byrom","year":"2002","unstructured":"Byrom J, Widjaja E, Redman CWE, Jones PW, Tebby S (2002) Can preoperative computer tomography predict resectabiity of ovarian carcinoma at primary laparotomy? Br J Obstet Gynecol 109: 369\u2013375","journal-title":"Br J Obstet Gynecol"},{"key":"BF6605292_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1006\/gyno.2000.5749","volume":"77","author":"DS Chi","year":"2000","unstructured":"Chi DS, Venkatraman ES, Masson V, Hoskins WJ (2000) The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. Gynecol Oncol 77: 227\u2013231","journal-title":"Gynecol Oncol"},{"key":"BF6605292_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ygyno.2008.10.010","volume":"112","author":"DS Chi","year":"2009","unstructured":"Chi DS, Zivanovic O, Palayekar MJ, Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Leitao MM, Brown CL, Barakat RR (2009) A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma. Gynecol Oncol 112: 6\u201310","journal-title":"Gynecol Oncol"},{"key":"BF6605292_CR9","first-page":"59","volume":"100","author":"BC Cooper","year":"2002","unstructured":"Cooper BC, Sood AK, Davis CS, Ritchie JM, Sorosky JL, Anderson B, Buller RE (2002) Preoperative CA-125 levels: an independent prognostic factor for epithelial ovarian cancer. Obstet Gynecol 100: 59\u201364","journal-title":"Obstet Gynecol"},{"key":"BF6605292_CR10","volume-title":"Analysis of Binary Data","author":"DR Cox","year":"1970","unstructured":"Cox DR (1970) Analysis of Binary Data. Methven: London"},{"key":"BF6605292_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/bmj.329.7458.168","volume":"329","author":"JJ Deeks","year":"2004","unstructured":"Deeks JJ, Altman DG (2004) Diagnostic tests 4: likelihood ratios. Br Med J 329: 168\u2013169","journal-title":"Br Med J"},{"key":"BF6605292_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/cncr.20376","volume":"101","author":"SC Dowdy","year":"2004","unstructured":"Dowdy SC, Mullany SA, Brandt KR, Huppert B, Cliby WA (2004) The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer 101: 346\u2013352","journal-title":"Cancer"},{"key":"BF6605292_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1006\/gyno.2001.6312","volume":"82","author":"SM Eisenkop","year":"2001","unstructured":"Eisenkop SM, Spirtos NM (2001) What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer? Gynecol Oncol 82: 489\u2013497","journal-title":"Gynecol Oncol"},{"key":"BF6605292_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ygyno.2006.07.004","volume":"103","author":"SM Eisenkop","year":"2006","unstructured":"Eisenkop SM, Spirtos NM, Lin WCM (2006) \u2018Optimal\u2019 cytoreduction for advanced epithelial ovarian cancer: a commentary. Gynecol Oncol 103: 329\u2013335","journal-title":"Gynecol Oncol"},{"key":"BF6605292_CR15","doi-asserted-by":"publisher","first-page":"642.e1","DOI":"10.1016\/j.ajog.2008.06.052","volume":"199","author":"A Fagotti","year":"2008","unstructured":"Fagotti A, Ferrandina G, Fanfani F, Garganese G, Vizzielli G, Carone V, Salerno MG, Scambia G (2008) Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. Am J Obstet Gynecol 199: 642.e1\u2013642.e6","journal-title":"Am J Obstet Gynecol"},{"key":"BF6605292_CR16","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1245\/ASO.2006.08.021","volume":"13","author":"A Fagotti","year":"2006","unstructured":"Fagotti A, Ferrandina MG, Fanfani F, Ercoli A, Lorusso D, Rossi M, Scambia G (2006) A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Ann Surg Oncol 13: 1156\u20131161","journal-title":"Ann Surg Oncol"},{"key":"BF6605292_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000074644","volume":"65","author":"F Fanfani","year":"2003","unstructured":"Fanfani F, Ferrandina G, Corrado G, Fagotti A, Zakut HV, Mancuso S, Scambia G (2003) Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO Stage IIIC ovarian cancer patients. Oncology 65: 16\u201322","journal-title":"Oncology"},{"key":"BF6605292_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1148\/radiology.197.3.7480729","volume":"197","author":"R Forstner","year":"1995","unstructured":"Forstner R, Hricak H, Occhipinti KA, Powell CB, Frankel SD, Stern JL (1995) Ovarian cancer: staging with CT and MR imaging. Radiology 197: 619\u2013626","journal-title":"Radiology"},{"key":"BF6605292_CR19","doi-asserted-by":"crossref","unstructured":"Gemer O, Gdalevich M, Ravid M, Piura B, Rabnovich A, Gasper T, Khashper A, Voldarsky M, Linov L, Ben Shacar I, Anteby EY, Lavie O (2009) A multicenter validation of computerized tomography models as predictors of non-optimal primary cytoreduction of advanced epithelial ovarian cancer. Eur J Surgical Oncol 1\u20134","DOI":"10.1016\/j.ejso.2009.03.002"},{"key":"BF6605292_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristics (ROC) curve. Radiology 143: 29\u201336","journal-title":"Radiology"},{"key":"BF6605292_CR21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/0002-9378(92)91658-W","volume":"166","author":"RW Hunter","year":"1992","unstructured":"Hunter RW, Alexander ND, Soutter WP (1992) Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis? Am J Obstet Gynecol 166: 504\u2013511","journal-title":"Am J Obstet Gynecol"},{"key":"BF6605292_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/ijgc-00009577-200303000-00003","volume":"13","author":"S Memarzadeh","year":"2003","unstructured":"Memarzadeh S, Lee SB, Berek JS, Farias-Esner R (2003) CA-125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer. Int J Gynecol Cancer 13: 120\u2013124","journal-title":"Int J Gynecol Cancer"},{"key":"BF6605292_CR23","doi-asserted-by":"publisher","first-page":"875","DOI":"10.2214\/ajr.165.4.7676985","volume":"165","author":"JI Meyer","year":"1995","unstructured":"Meyer JI, Kennedy AW, Friedman R, Hricak H, Occhipinti KA, Bethan Powell C, Frankel SD, Stern JL (1995) Ovarian carcinoma: value of CT in predicting success of debulking surgery. Am J Roentgenol 165: 875\u2013878","journal-title":"Am J Roentgenol"},{"key":"BF6605292_CR24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1200\/JCO.1993.11.1.166","volume":"11","author":"BE Nelson","year":"1993","unstructured":"Nelson BE, Rosenfield AT, Schwartz PE (1993) Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 11: 166\u2013172","journal-title":"J Clin Oncol"},{"key":"BF6605292_CR25","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1200\/JCO.2007.11.0932","volume":"25","author":"A Nickles Fader","year":"2007","unstructured":"Nickles Fader A, Rose P (2007) Role of surgery in ovarian carcinoma. J Clin Oncol 25: 2873\u20132883","journal-title":"J Clin Oncol"},{"key":"BF6605292_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ygyno.2004.06.054","volume":"96","author":"A Qayyum","year":"2005","unstructured":"Qayyum A, Coakley FV, Westphalan AC, Hricak H, Okuno WT, Powell B (2005) Role of CT and MRI imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol 96: 301\u2013306","journal-title":"Gynecol Oncol"},{"key":"BF6605292_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ygyno.2007.11.002","volume":"8","author":"S Risum","year":"2008","unstructured":"Risum S, H\u00f8gdall C, Loft A, Berthelsen AK, H\u00f8gdall E, Nedergaard L, Lundvall L, Engelholm SA (2008) Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography\/computed tomography-a prospective study. Gynecol Oncol 8: 265\u2013270","journal-title":"Gynecol Oncol"},{"key":"BF6605292_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1006\/gyno.2002.6719","volume":"86","author":"U Saygili","year":"2002","unstructured":"Saygili U, Guclu S, Uslu T, Erten O, Dogan E (2002) Can serum CA-125 levels predict the optimal primary cytoreduction in patients with advanced ovarian carcinoma? Gynecol Oncol 86: 57\u201361","journal-title":"Gynecol Oncol"},{"key":"BF6605292_CR29","unstructured":"Vergote I, Trope\u2019 CG, Amant F, Kristensen GB, Sardi JE, Ehelen T, Jonhson N, Verheijen RHM, Van der Burg MEL, Lacave AJ, Benedetti Panici P, Kenter GG, Casado A, Mendiola C, Coens C, Stuart G, Pecorelli S, Reed NS (2008) EORTC-GCG\/NCIC-CTG randomized trial comparing primary debulking surgery with neoadjuvant chemotherapy in stage IIIC-IV ovarian, fallopian tube and peritoneal cancer. Biennial International Gynecological Cancer Society Meeting; Bangkok, 25\u201328 October"},{"key":"BF6605292_CR30","first-page":"1615","volume":"19","author":"I Vergote","year":"2005","unstructured":"Vergote I, van Gorp T, Amant F, Neven P, Barteloot P (2005) Neoadjuvant chemotherapy for ovarian cancer. Oncology 19: 1615\u20131622","journal-title":"Oncology"},{"key":"BF6605292_CR31","doi-asserted-by":"publisher","first-page":"803","DOI":"10.6004\/jnccn.2008.0060","volume":"6","author":"MT Wakabayashi","year":"2008","unstructured":"Wakabayashi MT, Lin PS, Hakim AA (2008) The role of cytoreductive\/debulking surgery in ovarian cancer. J Natl Compr Cancer Network 6: 803\u2013810","journal-title":"J Natl Compr Cancer Network"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605292","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:41:49Z","timestamp":1684399309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,8]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["BF6605292"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605292","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,8]]}}}